Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Canada
  4. CANADIAN NATIONAL STOCK EXCHANGE
  5. 4Front Ventures Corp.
  6. News
  7. Summary
    FFNT   CA35086B2075

4FRONT VENTURES CORP.

(FFNT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

4Front Ventures Corp :. Debuts Terp Stix, an Award-Winning, Distillate-Infused Pre-Roll Brand to Illinois Cannabis Consumers

07/20/2021 | 08:30am EDT

PHOENIX - 4Front Ventures Corp. (CSE: FFNT) (OTCQX: FFNTF) ('4Front' or the 'Company'), a vertically integrated, multi-state cannabis operator and retailer, announced the launch of Terp Stix in Illinois. The Company's award-winning, distillate-infused pre-rolls are now available in one gram singles at 4Front's Mission Dispensaries in South Chicago and Calumet City, Illinois for $25.00. 4Front will continue to roll out its Terp Stix singles to partner dispensaries across the state in the coming weeks and months.

'The award-winning infused pre-rolls have been a huge hit among both lifestyle and medicinal consumers in markets like Washington and Massachusetts, and we're confident our customers in Illinois are going to fall in love with our Terp Stix singles,' said 4Front EVP of Retail Operations, Gabe Mendoza. 'With more than 20 recreational cannabis brands and 2,000 products, we believe our future success lies in our ability to bring first-rate, reasonably priced finished goods to market in a timely manner. As we look to add additional value to both our customers and shareholders, we remain focused on improving our operational efficiencies, streamlining our cultivation and production methodologies and capitalizing on our speed and agility in bringing products to market to gain a competitive marketplace advantage.'

According to the cannabis analytics firm Headset, in 2020, sales of cannabis pre-rolls surged nearly 50% in key adult-use markets, surpassing expectations during the global pandemic. Today, pre-rolls are the second-fastest-growing product category among cannabis consumers who shop for value products and enjoy the convenience of prepackaged consumer packaged goods.

Responding to growing consumer demand for high-quality products at affordable price points, 4Front designed its Terp Stix singles specifically for cannabis consumers who have a high tolerance using the Company's proprietary infusion process to homogenize its high-quality distillate and indoor-grown flower. Terp Stix pre-rolls deliver a smooth, controlled and canoe-free consumption experience, and are available to Illinois consumers in the following varieties: High Times Cannabis Cup winner Tiger's Blood; Blueberry; Green Apple; Pineapple; Strawberry; and Tangerine.

For more information, visit https://4frontventures.com/ and https://missiondispensaries.com/.

About 4Front Ventures Corp.

4Front Ventures Corp. ('4Front' of the 'Company') (CSE: FFNT) (OTCQX: FFNTF) is a national, vertically integrated multi-state cannabis operator with operations in strategic medical and adult-use cannabis markets, including California, Illinois, Massachusetts, Michigan and Washington. Since its founding in 2011, 4Front has built a strong reputation for its high standards and low-cost cultivation and production methodologies earned through a track record of success in facility design, cultivation, genetics, growing processes, manufacturing, purchasing, distribution, and retail. To date, 4Front has successfully brought to market more than 20 different cannabis brands and nearly 2,000 unique product lines, which are strategically distributed through its fully owned and operated Mission dispensaries and retail outlets in its core markets. As the Company continues to drive value for its shareholders, its team is applying its decade of expertise in the sector across the cannabis industry value chain and ecosystem. For more information, visit https://4frontventures.com/.

Contact:

4Front Investor

Andrew Thut

Chief Investment Officer

T: 602-633-3067

Media

Ellen Mellody

MATTIO Communications

T: 570-209-2947

E: ellen@mattio.com

(C) 2021 Electronic News Publishing, source ENP Newswire

All news about 4FRONT VENTURES CORP.
09/014FRONT VENTURES CORP : . Announces Upcoming Conference Participation
AQ
08/184FRONT VENTURES : Reports Second Quarter 2021 Financial Results and Provides Bus..
PU
08/184FRONT VENTURES CORP. : Results of Operations and Financial Condition, Financial..
AQ
08/174FRONT VENTURES : Management's Discussion and Analysis of Financial Condition an..
AQ
08/164Front Ventures Seeks Acquisitions
CI
08/164FRONT VENTURES : Reports Second Quarter 2021 Financial Results and Provides Bus..
AQ
08/164Front Ventures Corp. Announces Consolidated Earnings Results for the Second ..
CI
08/164Front Ventures Corp. Reiterates Earnings Guidance for the Fiscal Year 2021
CI
08/164FRONT VENTURES CORP : . to Open Its Third Dispensary in Massachusetts
AQ
08/164Front Ventures Corp. to Open its Third Dispensary in Massachusetts
CI
More news
Financials (USD)
Sales 2021 178 M - -
Net income 2021 - - -
Net Debt 2021 - - -
P/E ratio 2021 -
Yield 2021 -
Capitalization 623 M 624 M -
Capi. / Sales 2021 3,49x
Capi. / Sales 2022 2,65x
Nbr of Employees 405
Free-Float 66,4%
Chart 4FRONT VENTURES CORP.
Duration : Period :
4Front Ventures Corp. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 3
Last Close Price 1,34 CAD
Average target price 2,33 CAD
Spread / Average Target 74,1%
Managers and Directors
Leonid Gontmakher Chief Executive Officer & Director
Andrew Thut Chief Financial & Investment Officer
Kathi P. Lentzsch Chairman
Joseph Feltham Chief Operating Officer
David Daily Independent Director
Sector and Competitors
1st jan.Capi. (M$)
4FRONT VENTURES CORP.17.39%632
WALGREENS BOOTS ALLIANCE, INC.25.23%43 197
MCKESSON CORPORATION19.46%32 137
JD HEALTH INTERNATIONAL INC.-46.70%29 884
CARDINAL HEALTH, INC.-1.01%15 315
RAIA DROGASIL S.A.4.23%8 198